PLx Pharma Inc. Contracts & Agreements

Amendment No. 1 to Asset Purchase Agreement dated May 26, 2023 by and among PLx Pharma Inc., PLx Opco Inc. and PLx Acquisition Company, LLC (Filed With SEC on May 26, 2023)

Asset Purchase Agreement, dated April 12, 2023, by and among PLx Pharma Inc., PLx Opco Inc. and PLx Acquisition Company, LLC (Filed With SEC on April 12, 2023)

Severance and Settlement Agreement and Release of All Claims, dated February 9, 2023, by and between the Company and Michael Valentino (Filed With SEC on February 13, 2023)

PLx Pharma Inc. 2023 Key Executive Retention Plan (Filed With SEC on February 13, 2023)

Form of Award Notice under PLx Pharma Inc. 2023 Key Executive Retention Plan (Filed With SEC on February 13, 2023)

Award Notice, by and between PLx Pharma Inc. and Natasha Giordano, dated February 13, 2023 (Filed With SEC on February 13, 2023)

Award Notice, by and between PLx Pharma Inc. and Rita OConnor, dated February 13, 2023 (Filed With SEC on February 13, 2023)

Description of Registered Securities (Filed With SEC on March 11, 2022)

Second Amendment to Employment Agreement, dated August 3, 2021, by and between the Company and Rita OConnor (Filed With SEC on August 6, 2021)

Description of Registered Securities (Filed With SEC on March 12, 2021)

Underwriting Agreement, dated March 3, 2021, by and between PLx Pharma Inc. and Raymond James & Associates, Inc (Filed With SEC on March 3, 2021)

Termination Agreement dated March 2, 2021 (Filed With SEC on March 2, 2021)

Form of Warrant to Purchase Common Stock (Filed With SEC on November 16, 2020)

Form of Securities Purchase Agreement (Filed With SEC on November 16, 2020)

Form of Registration Rights Agreement (Filed With SEC on November 16, 2020)

Placement Agency Agreement, dated November 16, 2020, by and among the Company and Raymond James & Associates, Inc (Filed With SEC on November 16, 2020)

Description of Registered Securities (Filed With SEC on March 13, 2020)

Form of Certificate of Designations, Preferences and Rights of Series B Convertible Preferred Stock (Filed With SEC on March 13, 2020)

Form of Warrant (Filed With SEC on March 13, 2020)

Purchase Agreement, dated as of March 12, 2020, by and among the Company and the investors set forth on the signature pages thereto (Filed With SEC on March 13, 2020)

Registration Rights Agreement, dated as of March 12, 2020, by and among the Company and the investors set forth on the signature pages thereto (Filed With SEC on March 13, 2020)

Manufacturing Services Agreement, dated June 28, 2019, between the Company and Patheon Pharmaceuticals Inc (Filed With SEC on August 9, 2019)

Amendment to Employment Agreement with Natasha Giordano, dated March 7, 2019 (Filed With SEC on March 8, 2019)

Amendment to Employment Agreement with Rita OConnor, dated March 16, 2018 (Filed With SEC on March 8, 2019)

Amendment to Employment Agreement with Rita OConnor, dated March 7, 2019 (Filed With SEC on March 8, 2019)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on March 8, 2019)

Amendment to Employment Agreement with Michael Valentino, dated March 7, 2019 (Filed With SEC on March 8, 2019)

Form of Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock (Filed With SEC on December 21, 2018)

Form of Warrant (Filed With SEC on December 21, 2018)

Purchase Agreement, dated as of December 20, 2018, by and among the Company and the investors set forth on the signature pages thereto (Filed With SEC on December 21, 2018)

Registration Rights Agreement, dated as of December 20, 2018, by and among the Company and the investors set forth on the signature pages thereto (Filed With SEC on December 21, 2018)

2018 Incentive Plan (Filed With SEC on November 9, 2018)

Employment Agreement, dated as of August 29, 2018, by and between the Company and Efthymios Deliargyris (Filed With SEC on August 31, 2018)

Amendment to Amended and Restated Employment Agreement of Gary Mossman (Filed With SEC on September 19, 2017)

AMENDED AND RESTATED PATENT LICENSE AGREEMENT BETWEEN THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM AND PLX PHARMA INC. DATED DECEMBER 11, 2009 TABLE OF CONTENTS (Filed With SEC on August 15, 2017)

AMENDMENT NUMBER ONE TO AGREEMENT (Filed With SEC on August 15, 2017)

WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 10, 2017)

LOAN AND SECURITY AGREEMENT (Filed With SEC on August 10, 2017)

COMMON STOCK PURCHASE WARRANT PLX PHARMA INC. (Filed With SEC on June 12, 2017)

AMENDED AND RESTATED PATENT LICENSE AGREEMENT BETWEEN THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM AND PLX PHARMA INC. DATED DECEMBER 11, 2009 TABLE OF CONTENTS (Filed With SEC on June 12, 2017)

AMENDMENT NUMBER ONE TO AGREEMENT (Filed With SEC on June 12, 2017)

AMENDMENT NUMBER TWO TO AGREEMENT (Filed With SEC on June 12, 2017)

EMPLOYMENT AGREEMENT (Filed With SEC on May 2, 2017)

SEPARATION AND SETTLEMENT AGREEMENT AND RELEASE OF ALL CLAIMS (Filed With SEC on May 2, 2017)

EMPLOYMENT AGREEMENT (Filed With SEC on April 20, 2017)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on April 20, 2017)

PLX PHARMA INC. INDEMNIFICATION AGREEMENT (Filed With SEC on April 20, 2017)

AGREEMENT AND PLAN OF MERGER AND REORGANIZATION among PLX PHARMA INC. and DIPEXIUM PHARMACEUTICALS, INC. and DIPEXIUM ACQUISITION CORP. December 22, 2016 (Filed With SEC on December 22, 2016)

VOTING AGREEMENT among: DIPEXIUM PHARMACEUTICALS, INC., a Delaware corporation; PLX PHARMA INC., a Delaware corporation; and the undersigned Stockholder Dated as of December 22,... (Filed With SEC on December 22, 2016)

VOTING AGREEMENT among: PLX PHARMA INC., a Delaware corporation; DIPEXIUM PHARMACEUTICALS, INC., a Delaware corporation; and the undersigned Stockholder Dated as of December 22,... (Filed With SEC on December 22, 2016)

LOCK-UP AGREEMENT (Filed With SEC on December 22, 2016)

SEVERANCE AND RELEASE AGREEMENT (Filed With SEC on December 14, 2016)

************************************************************************ AGREEMENT OF LEASE Between ROZA 14W LLC, Landlord, and DIPEXIUM PHARMACEUTICALS, INC. Tenant, Dated: March... (Filed With SEC on February 17, 2016)

[__________] Shares* PLx Pharma Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 15, 2016)

[__________] Shares* PLx Pharma Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 5, 2016)

AMENDED AND RESTATED PATENT LICENSEAGREEMENT BETWEEN THE BOARD OF REGENTS OF THE UNIVERSITYOF TEXAS SYSTEM AND PLX PHARMA INC. DATED December11, 2009 (Filed With SEC on January 5, 2016)

AMENDMENT NUMBER TWO TO AGREEMENT (Filed With SEC on January 5, 2016)

AMENDEDAND RESTATED LICENSE& COMMERCIALIZATION AGREEMENT by and between LEE’SPHARMACEUTICAL holdings Limited, ZhaokePharmaceutical (HEFEI) Co. Ltd., lee’spharmaceutical (... (Filed With SEC on January 5, 2016)

PLX PHARMA INC. UNDERWRITING AGREEMENT (Filed With SEC on October 5, 2015)

PLXPHARMA INC. 2015OMNIBUS INCENTIVE PLAN ARTICLE 1 PURPOSE (Filed With SEC on October 5, 2015)

AMENDED AND RESTATED PATENT LICENSEAGREEMENT BETWEEN THE BOARD OF REGENTS OF THE UNIVERSITYOF TEXAS SYSTEM AND PLX PHARMA INC. DATED December11, 2009 (Filed With SEC on October 5, 2015)

AMENDMENT NUMBER ONE TO AGREEMENT (Filed With SEC on October 5, 2015)

AMENDMENT NUMBER TWO TO AGREEMENT (Filed With SEC on October 5, 2015)

AMENDEDAND RESTATED LICENSE& COMMERCIALIZATION AGREEMENT by and between LEE’SPHARMACEUTICAL holdings Limited, ZhaokePharmaceutical (HEFEI) Co. Ltd., lee’spharmaceutical (... (Filed With SEC on October 5, 2015)

AWARD AGREEMENT PLx Pharma Inc. 2015Omnibus Incentive Plan IncentiveStock Option (Filed With SEC on October 5, 2015)

AWARD AGREEMENT PLxPharma Inc. 2015 Omnibus Incentive Plan Non-QualifiedStock Option (Filed With SEC on October 5, 2015)

INDUSTRIALMULTI-TENANT LEASE TEACHERSINSURANCE AND ANNUITY ASSOCIATION OF AMERICA Landlord AND PLX PHARMAINC. Tenant (Filed With SEC on October 5, 2015)

FIRST AMENDMENTTO LEASE (Filed With SEC on October 5, 2015)

SECOND AMENDMENTTO LEASE (Filed With SEC on October 5, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on October 5, 2015)

PLX PHARMA INC. SCIENTIFIC ADVISORY BOARD AGREEMENT (Filed With SEC on October 5, 2015)

PLX PHARMA INC. INDEMNIFICATION AGREEMENT (Filed With SEC on October 5, 2015)

1,480,000 Shares Dipexium Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 25, 2015)

CONSULTING AGREEMENT (Filed With SEC on June 9, 2014)

NDA Regulatory Activities Scope of Services (May 2014 August 2014) (Filed With SEC on May 29, 2014)

SUBLEASE (Filed With SEC on May 13, 2014)

2,750,000 Shares Dipexium Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on March 18, 2014)

Shares Dipexium Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 24, 2014)

ASSET PURCHASE AGREEMENT between DIPEXIUM PHARMACEUTICALS, LLC and THE GENAERA LIQUIDATING TRUST, ARGYCE, LLC, as Trustee Dated April 8, 2010 (Filed With SEC on February 6, 2014)

STATE OF DELAWARE CERTIFICATE OF CONVERSION OF DIPEXIUM PHARMACEUTICALS, LLC FROM A DELAWARE LIMITED LIABILITY COMPANY TO A DELAWARE CORPORATION PURSUANT TO SECTION 265 OF THE... (Filed With SEC on February 6, 2014)

DIPEXIUM PHARMACEUTICALS, INC. 2013 EQUITY INCENTIVE PLAN (Filed With SEC on February 6, 2014)

DIRECTORS INDEMNIFICATION AGREEMENT (Filed With SEC on February 6, 2014)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on February 6, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on February 6, 2014)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 6, 2014)

COMMON STOCK PURCHASE WARRANT To Purchase Class A Membership Interests of DIPEXIUM PHARMACEUTICALS, LLC (Filed With SEC on February 6, 2014)

COMMON STOCK PURCHASE VV ARRANT To Purchase 500 Class A Membership Interests of DIPEXIUM PHARMACEUTICALS, LLC (Filed With SEC on February 6, 2014)

COMMON STOCK PURCHASE WARRANT To Purchase Class A Membership Interests of DIPEXIUM PHARMACEUTICALS, LLC (Filed With SEC on February 6, 2014)

MEMBERSHIP INTEREST PURCHASE WARRANT To Purchase Class A Membership Interests of DIPEXIUM PHARMACEUTICALS, LLC (Filed With SEC on February 6, 2014)

COMMON STOCK PURCHASE WARRANT To Purchase Class A Membership Interests of DIPEXIUM PHARMACEUTICALS, LLC (Filed With SEC on February 6, 2014)

INVESTOR RIGHTS AGREEMENT (Filed With SEC on February 6, 2014)

EXHIBIT A INVESTOR RIGHTS AGREEMENT JOINGER (Filed With SEC on February 6, 2014)

Confidential Treatment Requested by Dipexium Pharmaceuticals, LLC IRS Employer Identification No. 27-1707962 Confidential treatment requested with respect to certain portions... (Filed With SEC on February 6, 2014)

Bill of Sale and Assignment Agreement (Filed With SEC on February 6, 2014)

RESEARCH & DEVELOPMENT SERVICES AGREEMENT DPT LABORATORIES, LTD AND DIPEXIUM PHARMACEUTICALS, LLC (Filed With SEC on February 6, 2014)

LABORATORY SERVICES AGREEMENT (Filed With SEC on February 6, 2014)

MASTER SERVICES AGREEMENT (Filed With SEC on February 6, 2014)

Quality Agreement Dated as of September 3rd,2013 (the EFFECTIVE Date) By and Between PolyPeptide Laboratories San Diego (PPL-SD) And Dipexium Pharmaceuticals (Dipexium) (Filed With SEC on February 6, 2014)

ALMAC MASTER AGREEMENT FOR THE PROVISION OF PHARMACEUTICAL SUPPORT SERVICES (Filed With SEC on February 6, 2014)

MASTER AGREEMENT FOR SERVICES (Filed With SEC on February 6, 2014)

LICENSE AGREEMENT REGARDING MAGAININ PEPTIDE (Filed With SEC on February 6, 2014)

SECOND AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on February 6, 2014)

AGREEMENT (Filed With SEC on February 6, 2014)

SECOND AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on February 6, 2014)

PRODUCT DEVELOPMENT AGREEMENT (Filed With SEC on February 6, 2014)